Advertisement
Screener

AMICUS THERAPEUTICS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

AMICUS THERAPEUTICS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

AMICUS THERAPEUTICS, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$27.11 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.

Financial Statements › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2026-02-20

  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $1.69M, a 88.53% decline year-over-year.
  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $17.31M.
  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$24.42M.
  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$21.69M.
  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$27.11M.
  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$56.11M.
  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$151.58M.
  • AMICUS THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$236.57M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month
2025-12-31$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
$19.00M
derived: sum of 2 quarters · filed 2026-02-20
-$5.42M
derived: sum of 3 quarters · filed 2026-02-20
-$27.11M
10-K · filed 2026-02-20
2025-09-30$17.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$7.11M
derived: sum of 2 quarters · filed 2025-11-04
-$28.80M
10-Q · filed 2025-11-04
-$14.06M
derived: sum of 4 quarters · filed 2026-02-20
2025-06-30-$24.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$46.11M
10-Q · filed 2025-07-31
-$31.37M
derived: sum of 3 quarters · filed 2026-02-20
-$38.10M
derived: sum of 4 quarters · filed 2026-02-20
2025-03-31-$21.69M
10-Q · filed 2025-05-01
-$6.95M
derived: sum of 2 quarters · filed 2026-02-20
-$13.68M
derived: sum of 3 quarters · filed 2026-02-20
-$29.37M
derived: sum of 4 quarters · filed 2026-02-20
2024-12-31$14.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
$8.01M
derived: sum of 2 quarters · filed 2026-02-20
-$7.69M
derived: sum of 3 quarters · filed 2026-02-20
-$56.11M
10-K · filed 2026-02-20
2024-09-30-$6.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$22.43M
derived: sum of 2 quarters · filed 2025-11-04
-$70.84M
10-Q · filed 2025-11-04
-$104.69M
derived: sum of 4 quarters · filed 2026-02-20
2024-06-30-$15.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$64.12M
10-Q · filed 2025-07-31
-$97.96M
derived: sum of 3 quarters · filed 2026-02-20
-$119.54M
derived: sum of 4 quarters · filed 2026-02-20
2024-03-31-$48.42M
10-Q · filed 2025-05-01
-$82.26M
derived: sum of 2 quarters · filed 2026-02-20
-$103.84M
derived: sum of 3 quarters · filed 2026-02-20
-$147.07M
derived: sum of 4 quarters · filed 2026-02-20
2023-12-31-$33.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
-$55.42M
derived: sum of 2 quarters · filed 2026-02-20
-$98.65M
derived: sum of 3 quarters · filed 2026-02-20
-$151.58M
10-K · filed 2026-02-20
2023-09-30-$21.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$64.81M
derived: sum of 2 quarters · filed 2024-11-06
-$117.74M
10-Q · filed 2024-11-06
-$173.61M
derived: sum of 4 quarters · filed 2025-02-19
2023-06-30-$43.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$96.16M
10-Q · filed 2024-08-08
-$152.03M
derived: sum of 3 quarters · filed 2025-02-19
-$185.31M
derived: sum of 4 quarters · filed 2025-02-19
2023-03-31-$52.93M
10-Q · filed 2024-05-09
-$108.80M
derived: sum of 2 quarters · filed 2025-02-19
-$142.08M
derived: sum of 3 quarters · filed 2025-02-19
-$204.24M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31-$55.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
-$89.15M
derived: sum of 2 quarters · filed 2025-02-19
-$151.31M
derived: sum of 3 quarters · filed 2025-02-19
-$236.57M
10-K · filed 2025-02-19
2022-09-30-$33.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$95.44M
derived: sum of 2 quarters · filed 2023-11-08
-$180.70M
10-Q · filed 2023-11-08
-$263.98M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$62.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$147.42M
10-Q · filed 2023-08-08
-$230.69M
derived: sum of 3 quarters · filed 2024-02-28
-$280.99M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$85.26M
10-Q · filed 2023-05-10
-$168.54M
derived: sum of 2 quarters · filed 2024-02-28
-$218.83M
derived: sum of 3 quarters · filed 2024-02-28
-$270.06M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$83.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$133.57M
derived: sum of 2 quarters · filed 2024-02-28
-$184.80M
derived: sum of 3 quarters · filed 2024-02-28
-$250.46M
10-K · filed 2024-02-28
2021-09-30-$50.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$101.52M
derived: sum of 2 quarters · filed 2022-11-07
-$167.18M
10-Q · filed 2022-11-07
-$238.58M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$51.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$116.89M
10-Q · filed 2022-08-04
-$188.29M
derived: sum of 3 quarters · filed 2023-03-01
-$252.30M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$65.66M
10-Q · filed 2022-05-10
-$137.06M
derived: sum of 2 quarters · filed 2023-03-01
-$201.08M
derived: sum of 3 quarters · filed 2023-03-01
-$253.57M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$71.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$135.41M
derived: sum of 2 quarters · filed 2023-03-01
-$187.90M
derived: sum of 3 quarters · filed 2023-03-01
-$276.85M
10-K · filed 2023-03-01
2020-09-30-$64.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$116.50M
derived: sum of 2 quarters · filed 2021-11-09
-$205.45M
10-Q · filed 2021-11-09
-$295.18M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$52.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$141.44M
10-Q · filed 2021-08-05
-$231.17M
derived: sum of 3 quarters · filed 2022-02-24
-$292.98M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$88.95M
10-Q · filed 2021-05-10
-$178.68M
derived: sum of 2 quarters · filed 2022-02-24
-$240.49M
derived: sum of 3 quarters · filed 2022-02-24
-$325.04M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$89.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$151.54M
derived: sum of 2 quarters · filed 2022-02-24
-$236.09M
derived: sum of 3 quarters · filed 2022-02-24
-$356.39M
10-K · filed 2022-02-24
2019-09-30-$61.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$146.36M
derived: sum of 2 quarters · filed 2020-11-05
-$266.66M
10-Q · filed 2020-11-05
-$344.74M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$84.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$204.85M
10-Q · filed 2020-08-10
-$282.93M
derived: sum of 3 quarters · filed 2021-03-01
-$442.09M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$120.30M
10-Q · filed 2020-05-07
-$198.38M
derived: sum of 2 quarters · filed 2021-03-01
-$357.54M
derived: sum of 3 quarters · filed 2021-03-01
-$419.38M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$78.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$237.24M
derived: sum of 2 quarters · filed 2021-03-01
-$299.08M
derived: sum of 3 quarters · filed 2021-03-01
-$349.00M
10-K · filed 2021-03-01
2018-09-30-$159.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$221.00M
derived: sum of 2 quarters · filed 2019-11-12
-$270.91M
10-Q · filed 2019-11-12
-$340.12M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$61.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$111.75M
10-Q · filed 2019-08-08
-$180.96M
derived: sum of 3 quarters · filed 2020-03-02
-$292.62M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$49.92M
10-Q · filed 2019-05-09
-$119.12M
derived: sum of 2 quarters · filed 2020-03-02
-$230.79M
derived: sum of 3 quarters · filed 2020-03-02
-$278.93M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$69.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$180.87M
derived: sum of 2 quarters · filed 2020-03-02
-$229.01M
derived: sum of 3 quarters · filed 2020-03-02
-$284.00M
10-K · filed 2020-03-02
2017-09-30-$111.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
-$159.80M
derived: sum of 2 quarters · filed 2018-11-05
-$214.79M
10-Q · filed 2018-11-05
-$273.44M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$48.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$103.13M
10-Q · filed 2018-08-07
-$161.78M
derived: sum of 3 quarters · filed 2019-02-28
-$208.43M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$54.99M
10-Q · filed 2018-05-09
-$113.64M
derived: sum of 2 quarters · filed 2019-02-28
-$160.29M
derived: sum of 3 quarters · filed 2019-02-28
2016-12-31-$58.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$105.30M
derived: sum of 2 quarters · filed 2019-02-28
-$200.04M
10-K · filed 2019-02-28
2016-09-30-$46.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$141.40M
10-Q · filed 2017-11-08
2016-06-30-$94.74M
10-Q · filed 2017-08-07
2015-12-31-$132.12M
10-K · filed 2018-03-01